Skip to main content

Wealthfront Advisers LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1763921 Palo Alto, CA

Position in ALNY

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$2,876,040
-$957,750 QoQ
Shares Held
9,554
-17.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#285
of 784 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Wealthfront Advisers LLC holds $35,327,037 across 19 Biotechnology names. ALNY ranks #3 (8.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ALNY
Alnylam Pharmaceuticals, Inc.
This page
9,554 $2,876,040

All Filings in ALNY

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,876,040 9,554
2026-03-31 $3,833,790 11,587
2025-12-31 $7,258,703 18,254
2025-09-30 $6,119,520 13,420
2025-06-30 $3,940,471 12,084
2025-03-31 $2,354,844 8,721
2024-12-31 $2,969,612 12,620
2024-09-30 $2,281,648 8,296
2024-06-30 $1,967,328 8,096
2024-03-31 $1,209,050 8,090
2023-12-31 $2,217,484 11,585
2023-09-30 $2,188,424 12,357
2023-06-30 $5,251,081 27,646
2023-03-31 $6,873,580 34,313
2022-12-31 $7,744,062 32,586
2022-09-30 $3,678,140 18,376
2022-06-30 $2,059,110 14,118
2022-03-31 $2,097,460 12,845
2021-12-31 $223,676 1,319